A Systems Biology Roadmap to Decode mTOR Control System in Cancer

27Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mechanistic target of rapamycin (mTOR) is a critical protein in the regulation of cell fate decision making, especially in cancer cells. mTOR acts as a signal integrator and is one of the main elements of interactions among the pivotal cellular processes such as cell death, autophagy, metabolic reprogramming, cell growth, and cell cycle. The temporal control of these processes is essential for the cellular homeostasis and dysregulation of mTOR signaling pathway results in different phenotypes, including aging, oncogenesis, cell survival, cell growth, senescence, quiescence, and cell death. In this paper, we have proposed a systems biology roadmap to study mTOR control system, which introduces the theoretical and experimental modalities to decode temporal and dynamical characteristics of mTOR signaling in cancer.

Cite

CITATION STYLE

APA

Dorvash, M., Farahmandnia, M., & Tavassoly, I. (2020, March 1). A Systems Biology Roadmap to Decode mTOR Control System in Cancer. Interdisciplinary Sciences – Computational Life Sciences. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s12539-019-00347-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free